Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-25-004125
Filing Date
2025-05-23
Accepted
2025-05-23 14:54:44
Documents
1
Period of Report
2025-05-22

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 6597
  Complete submission text file 0001562180-25-004125.txt   8123
Mailing Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121
Business Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121 801-676-9695
Clene Inc. (Issuer) CIK: 0001822791 (see all company filings)

EIN.: 852828339 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 177 HUNTINGTON AVENUE, 21ST FLOOR BOSTON MA 02115
Business Address
Gay Jonathon (Reporting) CIK: 0001835422 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39834 | Film No.: 25981485